Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACET: Ropivacaine for Uteroplacental Blood Flow in Pre-Eclampsia and IUGR
NCT00197340Phase 3Completed
- Sponsor
- Hadassah Medical Organization
- Start
- Aug 2003
- Primary completion
- Dec 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ropivacaine in preeclampsia, fetal growth restriction (FGR), sponsored by Hadassah Medical Organization. Started Aug 2003; status: completed.
02
Drugs
ropivacaine
03
Conditions
preeclampsiafetal growth restriction (FGR)
Beyond the preview
Go deeper on NCT00197340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00197340.